研究者詳細

顔写真

イセ イチロウ
伊勢 一郎
Ichiro Ise
所属
病院 外科 胃腸外科
職名
助教
学位
  • 博士(医学)(東北大学)

e-Rad 研究者番号
20846042

学歴 2

  • 東北大学大学院医学系研究科

    2015年4月 ~ 2019年3月

  • 順天堂大学 医学部

    2005年4月 ~ 2011年3月

所属学協会 7

  • 日本大腸肛門病学会

  • 日本ロボット外科学会

  • 日本消化器病学会

  • 日本臨床外科学会

  • 日本内視鏡外科学会

  • 日本消化器外科学会

  • 日本外科学会

︎全件表示 ︎最初の5件までを表示

研究キーワード 3

  • 胆汁酸

  • 大腸癌

  • 減量・代謝改善手術

研究分野 1

  • ライフサイエンス / 消化器外科学 /

受賞 2

  1. 優秀演題セッション、理事長賞受賞

    2018年6月 第36回日本肥満症治療学会学術集会 十二指腸空腸バイパス手術における胆膵路の長さの違いが代謝に及ぼす影響とその機序の検討

  2. 優秀論文賞

    2018年 日本臨床外科学会雑誌 Endoscopic components separation法で修復した妊娠後発症白線ヘルニアの1例

論文 18

  1. Erratum forDoes Colorectal Stenting as a Bridge to Surgery for Obstructive Colorectal Cancer Increase Perineural Invasion?

    Hiroki Kato, Kazushige Kawai, Daisuke Nakano, Akira Dejima, Ichiro Ise, Soichiro Natsume, Misato Takao, Satomi Shibata, Toshiro Iizuka, Tetsuo Akimoto, Yuichiro Tsukada, Masaaki Ito

    Journal of the anus, rectum and colon 9 (1) 166-166 2025年

    DOI: 10.23922/jarc.E005  

    詳細を見る 詳細を閉じる

    [This corrects the article DOI: 10.23922/jarc.2023-057.].

  2. Surgical outcomes of a partial or total cystectomy for colorectal cancer invasion of the bladder. 国際誌

    Sakiko Nakamori, Kazushige Kawai, Akira Dejima, Soichiro Natsume, Ichiro Ise, Hiroki Kato, Misato Takao, Daisuke Nakano

    Asian journal of surgery 2024年11月22日

    DOI: 10.1016/j.asjsur.2024.10.196  

    詳細を見る 詳細を閉じる

    BACKGROUND: Although a partial or total cystectomy may be performed for colorectal cancer (CRC) with bladder invasion, the indications for either procedure have not been established. The present study reports the oncological and functional outcomes of CRC in patients who underwent combined resection of the bladder and CRC via either a partial or total cystectomy. METHODS: This retrospective study was conducted at a single center. A total of 107 consecutive patients with CRC who underwent colorectal surgery combined with partial or total cystectomy between January 2005 and August 2022 were enrolled. The short- and long-term outcomes of the surgery, especially postoperative bladder function, were assessed. RESULTS: Ninety patients underwent partial resection and 17 patients underwent total resection. Forty-two patients (46.7 %) in the partial cystectomy group and 16 (94.1 %) in the total cystectomy group had histologically confirmed CRC with bladder invasion. The urinary-specific morbidity rate was 18.9 % in the partial cystectomy group and 15.6 % patients in the same group required treatment for dysuria at postoperative month 3. Of the patients who underwent partial cystectomy, five (5.6 %) experienced recurrence stemming from a bladder remnant. The cumulative distant recurrence rates did not differ significantly between patients who underwent partial cystectomy and those who underwent total cystectomy (41.9 % and 57.4 %, respectively). CONCLUSION: Partial bladder resection contributes to the preservation of bladder function and yields oncologically acceptable outcomes.

  3. Modified neoadjuvant rectal score as a novel prognostic model for rectal cancer patients who underwent chemoradiotherapy.

    Kazushige Kawai, Kosuke Ozaki, Daisuke Nakano, Akira Dejima, Ichiro Ise, Sakiko Nakamori, Hiroki Kato, Soichiro Natsume, Misato Takao, Tatsuro Yamaguchi, Soichiro Ishihara

    International journal of clinical oncology 29 (7) 1012-1018 2024年7月

    DOI: 10.1007/s10147-024-02520-4  

    詳細を見る 詳細を閉じる

    BACKGROUND: The neoadjuvant rectal score (NAR score) has recently been proposed as a better prognostic model than the conventional TNM classification for rectal cancer patients that have undergone neoadjuvant chemoradiotherapy. We recently developed an apoptosis-detection technique for assessing the viability of residual tumors in resected specimens after chemoradiotherapy. This study aimed to establish an improved prognostic classification by combining the NAR score and the assessment of the apoptosis of residual cancer cells. METHODS: We retrospectively enrolled 319 rectal cancer patients who underwent chemoradiotherapy followed by radical surgery. The recurrence-free survival and overall survival of the four models were compared: TNM stage, NAR score, modified TNM stage by re-staging according to cancer cell viability, and modified NAR score also by re-staging. RESULTS: Downstaging of the ypT stage was observed in 15.5% of cases, whereas only 4.5% showed downstaging of ypN stage. C-index was highest for the modified NAR score (0.715), followed by the modified TNM, TNM, and NAR score. Similarly, Akaike's information criterion was smallest in the modified NAR score (926.2), followed by modified TNM, TNM, and NAR score, suggesting that the modified NAR score was the best among these four models. The overall survival results were similar: C-index was the highest (0.767) and Akaike's information criterion was the smallest (383.9) for the modified NAR score among the four models tested. CONCLUSION: We established a novel prognostic model, for rectal cancer patients that have undergone neoadjuvant chemoradiotherapy, using a combination of apoptosis-detecting immunohistochemistry and neoadjuvant rectal scores.

  4. Recurrence of rectal cancer on the pelvic sidewall after lateral lymph node dissection. 国際誌

    Misato Takao, Kazushige Kawai, Daisuke Nakano, Akira Dejima, Sakiko Nakamori, Soichiro Natsume, Ichiro Ise, Hiroki Kato, Tatsuro Yamaguchi

    International journal of colorectal disease 39 (1) 80-80 2024年5月28日

    DOI: 10.1007/s00384-024-04650-7  

    詳細を見る 詳細を閉じる

    PURPOSE: Although lateral lymph node dissection has been performed to prevent lateral pelvic recurrence in locally advanced lower rectal cancer, the incidence of lateral pelvic recurrence after this procedure has not been investigated. Therefore, this study aimed to investigate the long-term outcomes of patients who underwent lateral pelvic lymph node dissection, with a particular focus on recurrence patterns. METHODS: This was a retrospective study conducted at a single high-volume cancer center in Japan. A total of 493 consecutive patients with stage II-III rectal cancer who underwent lateral lymph node dissection between January 2005 and August 2022 were included. The primary outcome measures included patterns of recurrence, overall survival, and relapse-free survival. Patterns of recurrence were categorized as lateral or central pelvic. RESULTS: Among patients who underwent lateral lymph node dissection, 18.1% had pathologically positive lateral lymph node metastasis. Lateral pelvic recurrence occurred in 5.5% of patients after surgery. Multivariate analysis identified age > 75 years, lateral lymph node metastasis, and adjuvant chemotherapy as independent risk factors for lateral pelvic recurrence. Evaluation of the recurrence rate by dissection area revealed approximately 1% of recurrences in each area after dissection. CONCLUSION: We demonstrated the prognostic outcome and limitations of lateral lymph node dissection for patients with advanced lower rectal cancer, focusing on the incidence of recurrence in the lateral area after the dissection. Our study emphasizes the clinical importance of lateral lymph node dissection, which is an essential technique that surgeons should acquire.

  5. Hazard function analysis of prognosis after recurrent colorectal cancer. 国際誌

    Ichiro Ise, Kazushige Kawai, Daisuke Nakano, Misato Takao, Soichiro Natsume, Hiroki Kato, Sakiko Nakamori, Akira Dejima, Tatsuro Yamaguchi

    Langenbeck's archives of surgery 409 (1) 123-123 2024年4月13日

    DOI: 10.1007/s00423-024-03308-w  

    詳細を見る 詳細を閉じる

    BACKGROUND AND OBJECTIVES: Mean survival time (MST) is used as the indicator of prognosis in patients with a colorectal cancer (CRC) recurrence. The present study aimed to visualize the changes in death risk after a CRC recurrence using hazard function analysis (HFA) to provide an alternative prognostic indicator to MST. METHODS: The medical records of 725 consecutive patients with a recurrence following R0 radical surgery for CRC were retrospectively reviewed. RESULTS: The five-year, post-recurrence survival rate was 37.8%, and the MST was 3.5 years while the risk of death peaked at 2.9 years post-recurrence. Seven variables were found to predict short-term survival, including the number of metastatic organs ≥ 2, non-surgical treatment for the recurrence, and a short interval before recurrence. In patients with a recurrence in one organ, the MST was four years, the peak time of death predicted by HFA was 2.9 years, and the five-year survival rate was 45.8%. In patients with a surgical resection of the recurrence, the MST was 8 years, the peak time of death was 3.3 years, and the five-year survival rate was 62%. CONCLUSIONS: The present study established a novel method of assessing changes in mortality risk over time using HFA in patients with a CRC recurrence.

  6. Does Colorectal Stenting as a Bridge to Surgery for Obstructive Colorectal Cancer Increase Perineural Invasion?

    Hiroki Kato, Kazushige Kawai, Daisuke Nakano, Akira Dejima, Ichiro Ise, Soichiro Natsume, Misato Takao, Satomi Shibata, Toshiro Iizuka, Tetsuo Akimoto, Yuichiro Tsukada, Masaaki Ito

    Journal of the anus, rectum and colon 8 (3) 195-203 2024年

    DOI: 10.23922/jarc.2023-057  

    詳細を見る 詳細を閉じる

    OBJECTIVES: To clarify whether self-expandable metallic stent (SEMS) placement for obstructive colorectal cancer (CRC) increases perineural invasion (PNI), thereby worsening the prognosis. METHODS: In total, 1022 patients with pathological T3 or T4 colon or rectosigmoid cancer who underwent resection were retrospectively reviewed. The study patients were divided into a no obstruction group (n=693), obstruction without stent group (n=251), and obstruction with stent group (n=78), and factors demonstrating an independent association with PNI, the difference in PNI incidence and severity between groups, and the association between PNI and the duration from SEMS placement to surgery were investigated. Survival analysis was performed for each group. RESULTS: On multivariate analysis, SEMS placement (hazard ratio [HR]: 2.08) was independently associated with PNI whereas SEMS placement was not. PNI occurred in 39%, 45%, and 68% of the no obstruction, obstruction without stent, and obstruction with stent group, respectively. In the obstruction with stent group, the proportion of PNI was not associated with the duration from SEMS placement to surgery. Extramural PNI, an advanced form of PNI, demonstrated no increase with increasing interval. The five-year OS was 86.3%, 76.7%, and 73.1% in no obstruction, obstruction without stent, and obstruction with stent group, respectively. On multivariate analysis, obstruction was an independent risk factor of decreased OS (HR: 1.57) whereas SEMS placement was not. CONCLUSIONS: The prognosis was comparable between patients with SEMS placement and those with an obstruction who did not undergo SEMS placement, thus demonstrating that SEMS is a viable, therapeutic option for BTS.

  7. Laparoscopic or Robotically Assisted Colectomy with a Pfannenstiel Incision Reduces the Incisional Hernia Incidence.

    Soichiro Natsume, Tatsuro Yamaguchi, Daisuke Nakano, Misato Takao, Hiroki Kato, Ichiro Ise, Sakiko Nakamori, Akira Dejima, Kazushige Kawai

    Journal of the anus, rectum and colon 8 (4) 298-304 2024年

    DOI: 10.23922/jarc.2024-019  

    詳細を見る 詳細を閉じる

    OBJECTIVES: The present study examined the incidence of incisional hernia by comparing patients from whom a specimen was extracted either through a Pfannenstiel incision (PI) with an intracorporeal anastomosis or via a midline incision (MI) with an extracorporeal anastomosis. METHODS: The records of 370 consecutive patients who underwent a laparoscopic or robotically-assisted colectomy were retrospectively analyzed. Regardless of the clinical symptoms, incisional hernia was objectively diagnosed based on abdominal computed tomography findings. The surgical outcomes and incisional hernia incidence were retrospectively compared between the groups. Propensity score matching (PSM) was used to balance background differences between the groups. RESULTS: Eighty-seven and 283 patients were in the PI group and MI group, respectively. After PSM, 71 patients were selected from each group. The median observation time was 572 and 1110 days in the PI and MI group, respectively. The PI group had no incidence of incisional hernia whereas the MI group had a 14% incidence, demonstrating that the former had significantly fewer incisional hernias (p=0.0014). The median interval from surgery to incisional hernia development was 295 days. The PI with an intracorporeal anastomosis was not associated with an increased complication rate. CONCLUSIONS: The PI was preferable for intraoperative specimen extraction owing to the low, associated incidence of incisional hernia.

  8. Comparison of CEA and CA19-9 as a predictive factor for recurrence after curative gastrectomy in gastric cancer. 国際誌

    Chikashi Shibata, Toru Nakano, Akihiro Yasumoto, Atsushi Mitamura, Kentaro Sawada, Hitoshi Ogawa, Tomoya Miura, Ichiro Ise, Kazuhiro Takami, Kuniharu Yamamoto, Yu Katayose

    BMC surgery 22 (1) 213-213 2022年6月3日

    DOI: 10.1186/s12893-022-01667-z  

    詳細を見る 詳細を閉じる

    BACKGROUND: Our aim of was to compare importance of the tumor markers (TMs) serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 in prediction of recurrence after curative gastrectomy for gastric cancer. METHODS: We reviewed retrospectively the clinical records of 149 patients who underwent curative gastrectomy for stage I-III gastric cancer and whose CEA and CA19-9 levels were determined once preoperatively and for more than 3 years postoperatively. We investigated whether the clinicopathological characteristics of patients including age, sex, pathological disease stage, operative approach, type of gastrectomy, and degree of lymph node dissection as well as preoperative positivity of CEA and CA19-9 were risk factors for recurrence in univariate and multivariate analyses. Rate of recurrence was compared between patients positive and negative for postoperative CEA or CA19-9. We also calculated sensitivity, specificity, positive and negative predictable values of postoperative positivity of CEA and CA19-9 for recurrence. The lead time was compared between CEA and CA19-9 that was defined as the time of the first detection of increases in tumor markers and confirmation of recurrence on imaging modalities. RESULTS: The number of patients positive for preoperative CEA was 25 (17%) and for CA19-9 was 11 (7%). Recurrence was confirmed in 29 (19%) patients. Stage III disease, preoperative positivity for CA19-9 but not CEA, and total gastrectomy were risk factors for recurrence in univariate analysis, but stage III disease was the only risk factor for recurrence in multivariate analysis. Forty and 15 patients were positive for postoperative CEA and CA19-9, respectively. The recurrence rate of 47% (7/15) in patients positive for postoperative CA19-9 was greater than that in negative patients (22/134 = 16%), but it did not differ between patients who were positive or negative for postoperative CEA. Specificity for CA19-9 was greater than that for CEA (P < 0.05). The lead time of CEA (3.9 ± 4.7 months) was not different from that of CA19-9 (6.1 ± 7.1 months). CONCLUSIONS: These results indicate that CA19-9 rather than CEA is likely to be more useful for the detection of recurrence after curative gastrectomy for gastric cancer.

  9. ロボット支援下直腸切除術と開腹・腹腔鏡手術の プロペンシティスコアマッチングを用いた 長期予後の検討

    中野大輔 高雄美里 夏目壮一郎 加藤博樹 伊勢一郎 中守咲子 出嶋 皓 川合一茂

    2022年

  10. メッシュプラグのS状結腸穿通による腹壁膿瘍に対し腹腔鏡手術を施行した1例

    高見 一弘, 桜井, 博仁, 伊勢, 一郎, 山本, 久仁治, 柴田, 近 片寄 友

    2021年9月

  11. The evaluation of the safety and efficacy of intravenously administered allogeneic multilineage-differentiating stress-enduring cells in a swine hepatectomy model.

    Masahiro Iseki, Masamichi Mizuma, Shohei Wakao, Yoshihiro Kushida, Katsuyoshi Kudo, Masahiko Fukase, Masaharu Ishida, Tomoyuki Ono, Mitsuhiro Shimura, Ichiro Ise, Yukie Suzuki, Teruko Sueta, Ryuta Asada, Shinobu Shimizu, Yoshiyuki Ueno, Mari Dezawa, Michiaki Unno

    Surgery today 51 (4) 634-650 2021年4月

    DOI: 10.1007/s00595-020-02117-0  

    詳細を見る 詳細を閉じる

    INTRODUCTION: Multilineage-differentiating stress-enduring (Muse) cells are non-tumorigenic endogenous pluripotent-like cells residing in the bone marrow that exert a tissue reparative effect by replacing damaged/apoptotic cells through spontaneous differentiation into tissue-constituent cells. Post-hepatectomy liver failure (PHLF) is a potentially fatal complication. The main purpose of this study was to evaluate the safety and efficiency of allogeneic Muse cell administration via the portal vein in a swine model of PHLF. METHODS: Swine Muse cells, collected from swine bone marrow-mesenchymal stem cells (MSCs) as SSEA-3(+) cells, were examined for their characteristics. Then, 1 × 107 allogeneic-Muse cells and allogeneic-MSCs and vehicle were injected via the portal vein in a 70% hepatectomy swine model. RESULTS: Swine Muse cells exhibited characteristics comparable to previously reported human Muse cells. Compared to the MSC and vehicle groups, the Muse group showed specific homing of the administered cells into the liver, resulting in improvements in the control of hyperbilirubinemia (P = 0.04), prothrombin international normalized ratio (P = 0.05), and suppression of focal necrosis (P = 0.04). Integrated Muse cells differentiated spontaneously into hepatocyte marker-positive cells. CONCLUSIONS: Allogeneic Muse cell administration may provide a reparative effect and functional recovery in a 70% hepatectomy swine model and thus may contribute to the treatment of PHLF.

  12. 術前化学放射線療法施行後に手術を施行した局所進行下部直腸癌の術後短期成績 査読有り

    伊勢 一郎, 唐澤 秀明, 鈴木 秀幸, 神山 篤史, 渡辺 和宏, 大沼 忍, 亀井 尚, 内藤 剛, 海野 倫明

    日本大腸肛門病学会雑誌 73 (7) 358-358 2020年7月

    出版者・発行元: (一社)日本大腸肛門病学会

    ISSN:0047-1801

    eISSN:1882-9619

  13. Changes in Enterohepatic Circulation after Duodenal-Jejunal Bypass and Reabsorption of Bile Acids in the Bilio-Pancreatic Limb. 国際誌

    Ichiro Ise, Naoki Tanaka, Hirofumi Imoto, Masamitsu Maekawa, Atsushi Kohyama, Kazuhiro Watanabe, Fuyuhiko Motoi, Michiaki Unno, Takeshi Naitoh

    Obesity surgery 29 (6) 1901-1910 2019年6月

    DOI: 10.1007/s11695-019-03790-y  

    詳細を見る 詳細を閉じる

    BACKGROUND AND AIMS: Duodenal-jejunal bypass (DJB) shows great effects on weight loss and diabetes improvement. Previously, we reported that the bilio-pancreatic (BP) limb plays an important role in glycemic improvement and in serum bile acid (BA) level increase as reported by Miyachi et al. (Surgery 159(5):1360-71, 2016). This study aimed to investigate the mechanism of BA elevation after DJB and the relationship between these effects and BP-limb length. METHODS: Otsuka Long-Evans Tokushima Fatty rats with diabetes were randomly assigned into four groups: one sham group and three DJB groups. Three DJB groups were defined according to the BP-limb length: 0 cm, 15 cm, and 30 cm. The lengths of the alimentary limb and common channel were set equally in each DJB groups. Body weight, glucose tolerance, and BA levels in the liver, bile juice, portal vein, and intestinal contents were assessed postoperatively. Changes in enterohepatic circulation of BAs were assessed using labeled BA. RESULTS: BA elevation after DJB was higher with longer BP-limb. In the 30-cm group, the serum total BA level and BA levels in the portal vein, liver, and bile juice were greater than those in other groups. The enterohepatic circulation was shortened in the 15-cm and 30-cm groups. CONCLUSIONS: Shortening of the "enterohepatic circulation" by early reabsorption of BAs in the BP-limb, not by the early influx of bile juice into the ileum, was the main cause of BA elevation after DJB. Thus, glycemic improvement and elevation of BA concentration after DJB depend on the BP-limb length.

  14. 内視鏡治療後に追加切除を行った直腸神経内分泌腫瘍症例の検討

    大沼 忍, 神山 篤史, 鈴木 秀幸, 唐澤 秀明, 渡辺 和宏, 鈴木 ゆき恵, 金原 圭吾, 伊勢 一郎, 相澤 卓, 井本 博文, 山村 明寛, 青木 豪, 田中 直樹, 武者 宏昭, 元井 冬彦, 亀井 尚, 内藤 剛, 海野 倫明

    日本消化器病学会雑誌 116 (臨増総会) A360-A360 2019年3月

    出版者・発行元: (一財)日本消化器病学会

    ISSN:0446-6586

    eISSN:1349-7693

  15. Endoscopic components separation法で修復した妊娠後発症白線ヘルニアの1例

    伊勢 一郎 青木 豪 田中 直樹 武者 宏昭 海野 倫明 内藤 剛

    2018年11月

  16. 【敗血症・院内感染にいかに挑むか】待機的肝胆膵術後敗血症の術前リスク因子解析および予後の検討

    片寄 友 伊勢 一郎 林 洋毅 中川 圭 森川 孝則 水間 正道 大塚 英郎 武藤 満完 徳村 弘実 元井 冬彦 内藤 剛 海野 倫明

    2018年5月

  17. 肝切除を伴う胆道癌手術症例における敗血症発症の背景と長期予後

    片寄 友, 伊勢 一郎, 林 洋毅, 中川 圭, 森川 孝則, 元井 冬彦, 柴田 近, 内藤 剛, 海野 倫明

    日本外科学会定期学術集会抄録集 118回 987-987 2018年4月

    出版者・発行元: (一社)日本外科学会

  18. 腸管型ベーチェット病手術例の長期予後の検討

    伊勢 一郎, 渡辺, 和宏, 長尾, 宗紀, 大沼, 忍, 唐澤, 秀明, 鈴木, 秀幸, 内藤, 剛, 海野 倫明

    2018年3月

︎全件表示 ︎最初の5件までを表示

MISC 25

  1. 人工肛門造設を伴う腸管切除術により良好な経過を得られた腸管型ベーチェット病の一例

    安田 有希, 伊勢 一郎, 齋藤 達, 小野 智之, 梶原 大輝, 鈴木 秀幸, 唐澤 秀明, 渡辺 和宏, 大山 秀晃, 志賀 永嗣, 角田 洋一, 正宗 淳, 亀井 尚, 大沼 忍, 海野 倫明

    日本消化器病学会東北支部例会プログラム・抄録集 217回 93-93 2024年7月

    出版者・発行元: 日本消化器病学会-東北支部

  2. 再生医療の実現-外科医に期待される役割- ブタ70%肝切除モデルに対する経門脈同種Muse細胞移植

    伊関 雅裕, 水間 正道, 深瀬 正彦, 小野 智之, 志村 充広, 鈴木 ゆき恵, 伊勢 一郎, 石田 晶玄, 工藤 克昌, 林 洋毅, 元井 冬彦, 若尾 昌平, 串田 良祐, 亀井 尚, 石田 孝宣, 内藤 剛, 出澤 真理, 海野 倫明

    日本外科学会定期学術集会抄録集 120回 WS-2 2020年8月

    出版者・発行元: (一社)日本外科学会

  3. 術前化学放射線療法施行後に手術を施行した局所進行下部直腸癌の術後短期成績

    伊勢 一郎, 唐澤 秀明, 鈴木 秀幸, 神山 篤史, 渡辺 和宏, 大沼 忍, 亀井 尚, 内藤 剛, 海野 倫明

    日本大腸肛門病学会雑誌 73 (7) 358-358 2020年7月

    出版者・発行元: (一社)日本大腸肛門病学会

    ISSN: 0047-1801

    eISSN: 1882-9619

  4. 消化管の情報発信-臓器間ネットワークと肥満- 胆汁酸の動態から見たMetabolic surgeryの作用機序

    田中 直樹, 井本 博文, 伊勢 一郎, 上野 知尭, 市川 英孝, 渡辺 和宏, 神山 篤史, 大沼 忍, 武者 宏昭, 元井 冬彦, 亀井 尚, 海野 倫明, 内藤 剛

    肥満研究 25 (Suppl.) 161-161 2019年10月

    出版者・発行元: (一社)日本肥満学会

    ISSN: 1343-229X

  5. 消化管の情報発信-臓器間ネットワークと肥満- 胆汁酸の動態から見たMetabolic surgeryの作用機序

    田中 直樹, 井本 博文, 伊勢 一郎, 上野 知尭, 市川 英孝, 渡辺 和宏, 神山 篤史, 大沼 忍, 武者 宏昭, 元井 冬彦, 亀井 尚, 海野 倫明, 内藤 剛

    肥満研究 25 (Suppl.) 161-161 2019年10月

    出版者・発行元: (一社)日本肥満学会

    ISSN: 1343-229X

  6. 十二指腸空腸バイパス手術における胆膵路の長さの違いが代謝に及ぼす影響とその機序の検討

    伊勢 一郎, 田中 直樹, 井本 博文, 前川 正充, 神山 篤史, 渡辺 和宏, 元井 冬彦, 亀井 尚, 内藤 剛, 海野 倫明

    日本外科学会定期学術集会抄録集 119回 SF-035 2019年4月

    出版者・発行元: (一社)日本外科学会

  7. 内視鏡治療後に追加切除を行った直腸神経内分泌腫瘍症例の検討

    大沼 忍, 神山 篤史, 鈴木 秀幸, 唐澤 秀明, 渡辺 和宏, 鈴木 ゆき恵, 金原 圭吾, 伊勢 一郎, 相澤 卓, 井本 博文, 山村 明寛, 青木 豪, 田中 直樹, 武者 宏昭, 元井 冬彦, 亀井 尚, 内藤 剛, 海野 倫明

    日本消化器病学会雑誌 116 (臨増総会) A360-A360 2019年3月

    出版者・発行元: (一財)日本消化器病学会

    ISSN: 0446-6586

  8. 十二指腸空腸バイパス手術における胆膵路の長さの違いが代謝に及ぼす影響とその機序の検討

    伊勢 一郎, 田中 直樹, 上野 知尭, 小野 智之, 井本 博文, 神山 篤史, 渡辺 和宏, 前川 正充, 亀井 尚, 内藤 剛, 海野 倫明

    日本肥満症治療学会学術集会プログラム・抄録集 36回 107-107 2018年6月

    出版者・発行元: 日本肥満症治療学会

  9. 十二指腸空腸バイパス手術における胆膵路の長さの違いが代謝に及ぼす影響とその機序の検討

    伊勢一郎, 田中直樹, 上野知尭, 小野智之, 井本博文, 神山篤史, 渡辺和宏, 前川正充, 亀井尚, 内藤剛, 海野倫明

    日本肥満症治療学会学術集会プログラム・抄録集 36th 107-107 2018年6月

    出版者・発行元: 日本肥満症治療学会

  10. 当院の減量・代謝改善手術の治療成績と治療効果予測因子

    田中直樹, 井本博文, 伊勢一郎, 上野知堯, 青木豪, 山村明寛, 渡辺和宏, 神山篤史, 大沼忍, 武者宏昭, 元井冬彦, 亀井尚, 海野倫明, 内藤剛

    日本肥満症治療学会学術集会プログラム・抄録集 36th 108-108 2018年6月

    出版者・発行元: 日本肥満症治療学会

  11. 当院の減量・代謝改善手術の治療成績と治療効果予測因子

    田中 直樹, 井本 博文, 伊勢 一郎, 上野 知尭, 青木 豪, 山村 明寛, 渡辺 和宏, 神山 篤史, 大沼 忍, 武者 宏昭, 元井 冬彦, 亀井 尚, 海野 倫明, 内藤 剛

    日本肥満症治療学会学術集会プログラム・抄録集 36回 108-108 2018年6月

    出版者・発行元: 日本肥満症治療学会

  12. 肝切除を伴う胆道癌手術症例における敗血症発症の背景と長期予後

    片寄 友, 伊勢 一郎, 林 洋毅, 中川 圭, 森川 孝則, 元井 冬彦, 柴田 近, 内藤 剛, 海野 倫明

    日本外科学会定期学術集会抄録集 118回 987-987 2018年4月

    出版者・発行元: (一社)日本外科学会

  13. 手術を要した腸管型ベーチェット病の再発形式と長期予後

    伊勢 一郎, 渡辺 和宏, 長尾 宗紀, 大沼 忍, 唐澤 秀明, 鈴木 秀幸, 武者 宏昭, 元井 冬彦, 石田 孝宣, 亀井 尚, 内藤 剛, 海野 倫明

    日本外科学会定期学術集会抄録集 118回 2344-2344 2018年4月

    出版者・発行元: (一社)日本外科学会

  14. 2区域以上の肝切除例における敗血症の発症率と長期予後

    片寄 友, 伊勢 一郎, 林 洋毅, 武藤 満完, 中川 圭, 森川 孝則, 元井 冬彦, 内藤 剛, 海野 倫明

    日本外科感染症学会雑誌 14 (5) 641-641 2017年10月

    出版者・発行元: (一社)日本外科感染症学会

    ISSN: 1349-5755

  15. 全身麻酔不能な肺高血圧症を合併した繰り返す閉鎖孔ヘルニア嵌頓に対して、整復後に待機的前方アプローチで修復した1例

    伊勢 一郎, 田中 直樹, 鈴木 秀幸, 井本 博文, 唐澤 秀明, 青木 豪, 工藤 克昌, 渡辺 和宏, 長尾 宗紀, 大沼 忍, 武者 宏昭, 元井 冬彦, 亀井 尚, 内藤 剛, 海野 倫明

    日本臨床外科学会雑誌 78 (増刊) 930-930 2017年10月

    出版者・発行元: 日本臨床外科学会

    ISSN: 1345-2843

  16. 肝切除を伴う胆道癌手術における敗血症の検討

    片寄 友, 伊勢 一郎, 林 洋毅, 中川 圭, 森川 孝則, 水間 正道, 大塚 英郎, 武藤 満完, 松村 直樹, 野村 良平, 徳村 弘実, 元井 冬彦, 内藤 剛, 海野 倫明

    胆道 31 (3) 529-529 2017年8月

    出版者・発行元: 日本胆道学会

    ISSN: 0914-0077

  17. 腹腔鏡下スリーブバイパス術後に血清鉄、亜鉛は低下する

    伊勢 一郎, 田中 直樹, 河野 えみ子, 土屋 堯裕, 井本 博文, 渡辺 和宏, 長尾 宗紀, 内藤 剛, 海野 倫明

    日本肥満症治療学会学術集会プログラム・抄録集 35回 141-141 2017年6月

    出版者・発行元: 日本肥満症治療学会

  18. 十二指腸空腸バイパス術後のエネルギー代謝におけるbiliopancreatic limbの役割

    河野 えみ子, 長尾 宗紀, 上野 知尭, 伊勢 一郎, 土屋 堯裕, 井本 博文, 田中 直樹, 武者 宏昭, 内藤 剛, 海野 倫明

    日本肥満症治療学会学術集会プログラム・抄録集 35回 104-104 2017年6月

    出版者・発行元: 日本肥満症治療学会

  19. 敗血症・院内感染にいかに挑むか 長期予後から検討した待機的肝胆膵手術における敗血症の意義

    片寄 友, 武藤 満完, 伊勢 一郎, 林 洋毅, 中川 圭, 森川 孝則, 水間 正道, 大塚 英郎, 高橋 賢一, 西條 文人, 松村 直樹, 野村 良平, 安本 明浩, 羽根田 祥, 徳村 弘実, 元井 冬彦, 内藤 剛, 海野 倫明

    日本腹部救急医学会雑誌 37 (2) 241-241 2017年2月

    出版者・発行元: (一社)日本腹部救急医学会

    ISSN: 1340-2242

  20. Long-term experience with intestinal Behcet's disease after surgery

    Ichiro Ise, Kazuhiro Watanabe, Munenori Nagao, Tomoya Abe, Hideaki Karasawa, Shinobu Ohnuma, Hiroaki Musha, Fuyuhiko Motoi, Takeshi Naitoh, Michiaki Unno

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 31 177-177 2016年11月

    ISSN: 0815-9319

    eISSN: 1440-1746

  21. BACKGROUND OF MAJOR HEPATO-BILIARY-PANCREATIC SURGERY-INDUCED SEPSIS

    Yu Katayose, Ichiro Ise, Hiroki Hayashi, Mitsuhisa Mutoh, Kei Nakagawa, Takanori Morikawa, Fuyuhiko Motoi, Takeshi Naitoh, Michiaki Unno

    SHOCK 46 (4) 25-26 2016年10月

    ISSN: 1073-2322

    eISSN: 1540-0514

  22. LSG施行後5年目にrevision surgeryとして再LSG/DJBを施行した糖尿病合併重症肥満の1例

    伊勢 一郎, 田中 直樹, 河野 えみ子, 土屋 堯裕, 井本 博文, 渡辺 和宏, 長尾 宗紀, 武者 宏昭, 澤田 正二郎, 片桐 秀樹, 岡本 智子, 武田 みゆき, 内藤 剛, 海野 倫明

    日本肥満症治療学会学術集会プログラム・抄録集 34回 75-75 2016年7月

    出版者・発行元: 日本肥満症治療学会

  23. 術前減量を考慮して腹腔鏡下スリーブ状胃切除術の治療効果を検討する

    田中 直樹, 内藤 剛, 伊勢 一郎, 河野 えみ子, 土屋 堯裕, 井本 博文, 渡辺 和宏, 長尾 宗紀, 武者 宏昭, 澤田 正二郎, 片桐 秀樹, 武田 みゆき, 岡本 智子, 元井 冬彦, 海野 倫明

    日本肥満症治療学会学術集会プログラム・抄録集 34回 77-77 2016年7月

    出版者・発行元: 日本肥満症治療学会

  24. 当科における腸管型ベーチェット病症例の特徴および術後長期予後の検討

    伊勢 一郎, 渡辺 和宏, 長尾 宗紀, 阿部 友哉, 大沼 忍, 唐澤 秀明, 武者 宏昭, 元井 冬彦, 内藤 剛, 海野 倫明

    日本消化器外科学会総会 71回 P3-44 2016年7月

    出版者・発行元: (一社)日本消化器外科学会

  25. 膵頭十二指腸切除術後4年目に挙上空腸の静脈瘤から出血し、内視鏡的硬化療法にて救命した1例

    伊勢 一郎, 石田 晶玄, 前田 晋平, 岡田 良, 深瀬 耕二, 森川 孝則, 中川 圭, 林 洋毅, 元井 冬彦, 内藤 剛, 海野 倫明

    日本臨床外科学会雑誌 76 (増刊) 896-896 2015年10月

    出版者・発行元: 日本臨床外科学会

    ISSN: 1345-2843

︎全件表示 ︎最初の5件までを表示

共同研究・競争的資金等の研究課題 1

  1. 食餌誘発性肥満による大腸癌発癌メカニズムの解明

    伊勢 一郎

    2026年4月1日 ~ 2029年3月31日